Research Article
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
Table 1
Demographic and baseline characteristics (safety population).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FCM = ferric carboxymaltose; SD = standard deviation; SMC = standard medical care. for ferric carboxymaltose and for standard medical care. for ferric carboxymaltose and for standard medical care. Prepregnancy weight for postpartum subjects only; for ferric carboxymaltose and for standard medical care. If a subject had ≤1 cardiac risk factor (specifically, smoking, high blood pressure, high blood cholesterol, diabetes, overweight or obese, physical inactivity, or family history of heart disease), the subject was categorized as low cardiac risk; if the subject had ≥2 risk factors, they were categorized as high cardiac risk. for ferric carboxymaltose and for standard medical care. for ferric carboxymaltose and for standard medical care. |